ibudilast has been researched along with Amphetamine Abuse in 6 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| "Stress and renewed contact with drug (a "slip") have been linked to persisting relapse of methamphetamine abuse." | 3.76 | The glial cell modulator and phosphodiesterase inhibitor, AV411 (ibudilast), attenuates prime- and stress-induced methamphetamine relapse. ( Beardsley, PM; Hendrick, E; Johnson, KW; Shelton, KL, 2010) |
| "Adult, non-treatment seeking, MA-dependent volunteers (N=11) received oral placebo, moderate ibudilast (40 mg), and high-dose ibudilast (100mg) via twice-daily dosing for 7 days each in an inpatient setting." | 2.82 | Ibudilast attenuates subjective effects of methamphetamine in a placebo-controlled inpatient study. ( Heinzerling, KG; Roche, DJ; Shoptaw, S; Swanson, A-N; Worley, MJ, 2016) |
| "Ibudilast treatment had similar rates of adverse events compared with placebo, and there was no significant augmentation of cardiovascular effects of methamphetamine." | 2.82 | Safety of Intravenous Methamphetamine Administration During Ibudilast Treatment. ( Andrenyak, DM; DeYoung, DZ; Furst, BA; Heinzerling, KG; Moody, DE; Shoptaw, SJ; Swanson, AN; Tsuang, J; Wu, YN; Yi, Y, 2016) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 4 (66.67) | 24.3611 |
| 2020's | 2 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Li, MJ | 1 |
| Briones, MS | 1 |
| Heinzerling, KG | 4 |
| Kalmin, MM | 1 |
| Shoptaw, SJ | 3 |
| Briones, M | 2 |
| Thames, AD | 1 |
| Hinkin, CH | 1 |
| Zhu, T | 1 |
| Wu, YN | 2 |
| Birath, JB | 1 |
| Amaya, S | 1 |
| Shoptaw, S | 2 |
| Swanson, AN | 2 |
| Tsuang, J | 2 |
| Furst, B | 1 |
| Heinzerling, K | 1 |
| Obermeit, L | 1 |
| Maes, L | 1 |
| McKay, C | 1 |
| Wright, MJ | 1 |
| Worley, MJ | 1 |
| Swanson, A-N | 1 |
| Roche, DJ | 1 |
| DeYoung, DZ | 1 |
| Furst, BA | 1 |
| Yi, Y | 1 |
| Moody, DE | 1 |
| Andrenyak, DM | 1 |
| Beardsley, PM | 1 |
| Shelton, KL | 1 |
| Hendrick, E | 1 |
| Johnson, KW | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Screen, Treat and Retain Meth-using People With Opioid Use Disorders at Methadone Clinics[NCT04706624] | 640 participants (Anticipated) | Interventional | 2020-11-02 | Active, not recruiting | |||
| Regeneration in Cervical Degenerative Myelopathy - a Multi-centre, Double-blind, Randomised, Placebo Controlled Trial Assessing the Efficacy of Ibudilast as an Adjuvant Treatment to Decompressive Surgery for Degenerative Cervical Myelopathy[NCT04631471] | Phase 3 | 400 participants (Anticipated) | Interventional | 2021-12-22 | Recruiting | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
4 trials available for ibudilast and Amphetamine Abuse
| Article | Year |
|---|---|
Ibudilast attenuates peripheral inflammatory effects of methamphetamine in patients with methamphetamine use disorder.
Topics: Adult; Amphetamine-Related Disorders; Animals; Central Nervous System Stimulants; Cross-Over Studies | 2020 |
Randomized, Placebo-Controlled Trial of Targeting Neuroinflammation with Ibudilast to Treat Methamphetamine Use Disorder.
Topics: Adult; Amphetamine-Related Disorders; Central Nervous System Stimulants; Double-Blind Method; Female | 2020 |
Ibudilast attenuates subjective effects of methamphetamine in a placebo-controlled inpatient study.
Topics: Adult; Amphetamine-Related Disorders; Cross-Over Studies; Double-Blind Method; Female; Humans; Inpat | 2016 |
Safety of Intravenous Methamphetamine Administration During Ibudilast Treatment.
Topics: Administration, Intravenous; Adult; Amphetamine-Related Disorders; Central Nervous System Stimulants | 2016 |
2 other studies available for ibudilast and Amphetamine Abuse
| Article | Year |
|---|---|
Ibudilast may improve attention during early abstinence from methamphetamine.
Topics: Amphetamine-Related Disorders; Attention; Humans; Impulsive Behavior; Methamphetamine; Pyridines; Re | 2017 |
The glial cell modulator and phosphodiesterase inhibitor, AV411 (ibudilast), attenuates prime- and stress-induced methamphetamine relapse.
Topics: Amphetamine-Related Disorders; Animals; Dose-Response Relationship, Drug; Injections, Intraperitonea | 2010 |